2013Chinese Journal of Family Planning & GynecotokologyRequires access

The progress in diagnosis and treatment of ovarian cancer

Lingling Tong

Open publisher page 1 citations

Abstract

The early diagnosis of ovarian cancer has been relied on the classical tumor marker cancer antigen 125 (CA_125),as well as transvaginal ultrasonography (TVS).Recently,the new markers of human epididymis protein 4 (HE_4) and proteomics become very important for monitoring ovarian cancer pathogenesis,treatment,clinical outcome and recurrence.The normative and thoroughness of the initial surgery for ovarian cancer are critical to the proper surgery and chemotherapy.Early ovarian cancer should conduct a comprehensive staging operation.When necessary,the re-staging should be done before chemotherapy.In advanced stage of ovarian cancer,it had better to do cytoreductive surgery,in combination with neoadjuvant chemotherapy.After early diagnosis and standard treatment,the survival rate of ovarian cancer has been increased significantly,however,gynecological oncologist can not ignore the high relapse rate and mortality.

About this research paper

What this paper is about

The early diagnosis of ovarian cancer has been relied on the classical tumor marker cancer antigen 125 (CA_125),as well as transvaginal ultrasonography (TVS).Recently,the new markers of human epididymis protein 4 (HE_4) and proteomics become very important for monitoring ovarian cancer pathogenesis,treatment,clinical outcome and recurrence.The normative and thoroughness of the initial surgery for ovarian cancer are critical to the proper surgery and chemotherapy.Early ovarian cancer should conduct a comprehensive staging operation.When necessary,the re-staging should be done before chemotherapy.In advanced stage of ovarian cancer,it had better to do cytoreductive surgery,in combination with neoadjuvant chemotherapy.After early diagnosis and standard treatment,the survival rate of ovarian cancer has been increased significantly,however,gynecological oncologist can not ignore the high relapse rate and mortality.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The early diagnosis of ovarian cancer has been relied on the classical tumor marker cancer antigen 125 (CA_125),as well as transvaginal ultrasonography (TVS).Recently,the new markers of human epididymis protein 4 (HE_4) and proteomics become very important for monitoring ovarian cancer pathogenesis,treatment,clinical outcome and recurrence.The normative and thoroughness of the initial surgery for ovarian cancer are critical to the proper surgery and chemotherapy.Early ovarian cancer should conduct a comprehensive staging operation.When necessary,the re-staging should be done before chemotherapy.In advanced stage of ovarian cancer,it had better to do cytoreductive surgery,in combination with neoadjuvant chemotherapy.After early diagnosis and standard treatment,the survival rate of ovarian cancer has been increased significantly,however,gynecological oncologist can not ignore the high relapse rate and mortality.

Key concepts: Medicine, Ovarian cancer, Chemotherapy, Stage (stratigraphy), Oncology, Cancer antigen, Cancer, Cytoreductive surgery

Related papers

Back to paper searchBrowse research topicsOriginal source
The progress in diagnosis and treatment of ovarian cancer — Research Paper | ScholarLens